Cargando…

Infliximab in the treatment of refractory uveitis. Does dose really matter?

Detalles Bibliográficos
Autores principales:	Sukumaran, MD Sukesh, Marzan, MD Katherine, Reiff, MD Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194579/ http://dx.doi.org/10.1186/1546-0096-9-S1-P219

Ejemplares similares

High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?
por: Sukumaran, Sukesh, et al.
Publicado: (2012)

Decannulation: in the ICU or in the ward? Does it really matter?
por: Milercy, O, et al.
Publicado: (2011)

Source of ICU admission: does it really matter?
por: Datta, A, et al.
Publicado: (2015)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)
por: Miranda, V, et al.
Publicado: (2013)

Successful treatment of refractory hughes stovin syndrome with infliximab
por: Gortani, Giulia, et al.
Publicado: (2014)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Does the coagulation profile really matter in central venous cannulation? A review of the literature
por: Baombe, J, et al.
Publicado: (2011)

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
por: Vougiouka, O, et al.
Publicado: (2011)

Efficacy of high dose methotrexate in pediatric auto-immune uveitis
por: Armbrust, Wineke, et al.
Publicado: (2014)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Implementation of the protocol of decompressive craniectomy: does it really improve outcome?
por: Missaka, H, et al.
Publicado: (2009)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011)

Early treatment with infliximab in patients with juvenile idiopathic arthritis
por: Sleptsova, TV, et al.
Publicado: (2011)

Lethal chickenpox infection during treatment with infliximab and methotrexate
por: Estmann, A, et al.
Publicado: (2011)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
por: Xiong, Anji, et al.
Publicado: (2021)

Effect of intra-arterial nimodipine in patients with subarachnoid hemorrhage and refractory vasospasm: a pilot study
por: Kurtz, PMP, et al.
Publicado: (2005)

Infliximab treatment does not induce apoptosis in peripheral blood mononuclear cells up to 24 hours after initiation of treatment in rheumatoid arthritis patients
por: Wijbrandts, CA, et al.
Publicado: (2005)

Is this admission really relevant?
por: Folkestad, Lars, et al.
Publicado: (2009)

A Child with X-Linked Agammaglobulinemia and Enthesitis-Related Arthritis
por: Sukumaran, Sukesh, et al.
Publicado: (2011)

Non-anti TNF biologic modifier drugs in non-infectious refractory chronic uveitis: the current evidence from a systematic review
por: Simonini, Gabriele, et al.
Publicado: (2014)

First results of the uveitis outcome study of the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2014)

ELDER ABUSE BY FAMILY CAREGIVER: DOES COGNITIVE IMPAIRMENT REALLY MATTER?
por: Yan, Elsie
Publicado: (2019)

PReS-FINAL-2266: A rare cause for childhood uveitis: TINU (tubulointerstitial nephritis and uveitis) syndrome
por: Barut, K, et al.
Publicado: (2013)

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
por: Alfawaz, Abullah, et al.
Publicado: (2014)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Severe asthma is really uncommon
por: Zicari, Anna Maria, et al.
Publicado: (2013)

Does size really matter?
por: Heckel, David G
Publicado: (2020)

Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003)

TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
por: Konopelko, OU, et al.
Publicado: (2011)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
por: Martin, Fabiola, et al.
Publicado: (2014)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

Effect of infliximab in sweet’s syndrome-pyoderma gangraenosum overlap syndrome
por: Mahler, Birgitte, et al.
Publicado: (2014)

Specific PKG inhibitors: do they really exist?
por: Gambaryan, Stepan, et al.
Publicado: (2011)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
por: Henry, Alistair I, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ftimmeugfp66n0v9chvpd78mu2